Use of radiograph scoring systems to assess pulmonary disease severity in patients with COVID-19 pneumonia

doi:10.5492/wjccm.v15.i1.113684

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

This Article

(43)

(54)

(0)

(19)

(1)

(702)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.

World J Crit Care Med. Mar 9, 2026; 15(1): 113684
Published online Mar 9, 2026. doi: 10.5492/wjccm.v15.i1.113684

Table 1 Summary of demographic characteristics, BRIXIA and Radiographic Assessment of Lung Edema scores, and oxygen use via oxygen delivery device, n (%)

Category	Variable	Summary
Total sample size	n	950 (100.0)
Demographics	Age (mean ± SD)	48.4 (13.6)
Demographics	Male	861 (90.6)
Chest X-ray scores, median (IQR)	BRIXIA	8.0 (6.0)
Chest X-ray scores, median (IQR)	RALE	12.0 (16.0)
Comorbidities	No comorbidities	475 (50.0)
	Diabetes mellitus	306 (32.2)
	Hypertension	293 (30.8)
	Coronary artery disease/CHF	59 (6.2)
	Asthma/COPD	35 (3.7)
	Chronic kidney disease	36 (3.7)
	Others	68 (7.1)
Clinical variables median (IQR)	Temperature	38.0 (1.3)
	Respiratory rate	22.0 (6.0)
	Heart rate	102.0 (24.3)
	Systolic blood pressure	129.0 (23.0)
	White blood cells	6.8 (4.0)
	C-reactive protein	71.5 (97.9)
Oxygen delivery device use in ED	Room air	481 (50.6)
	Nasal cannula	338 (35.6)
	Hudson mask	22 (2.3)
	NRBM	89 (9.4)
	HFNC/CPAP/BiPAP	20 (2.1)
Oxygen device used during hospitalization	Nasal cannula	890 (93.7)
	Hudson mask	14 (1.5)
	NRBM	383 (40.3)
	HFNC/CPAP/BiPAP	182 (19.2)
	Oral intubation/tracheostomy	133 (14.0)

n: Number of participants; IQR: Interquartile range; RALE: Radiographic Assessment of Lung Edema; CHF: Congestive heart failure; COPD: Chronic obstructive pulmonary disease; ED: Emergency department; NRBM: Non-rebreather mask; HFNC: High flow nasal cannula; CPAP: Continuous positive airway pressure; BiPAP: Bi-level positive airway pressure.

Full Size Table

Citation: Mohammed H, Y Fadul K, Naqvi SGA, Kharma N, Alfian Yusof A, Ahmad S, Farooq M, Javid S, Mohamed A, Abdel-Rahman ME, Harris T. Use of radiograph scoring systems to assess pulmonary disease severity in patients with COVID-19 pneumonia. World J Crit Care Med 2026; 15(1): 113684
URL: https://www.wjgnet.com/2220-3141/full/v15/i1/113684.htm
DOI: https://dx.doi.org/10.5492/wjccm.v15.i1.113684

Mohammed H, Y Fadul K, Naqvi SGA, Kharma N, Alfian Yusof A, Ahmad S, Farooq M, Javid S, Mohamed A, Abdel-Rahman ME, Harris T. Use of radiograph scoring systems to assess pulmonary disease severity in patients with COVID-19 pneumonia. World J Crit Care Med 2026; 15(1): 113684 [PMID: 41883765 DOI: 10.5492/wjccm.v15.i1.113684]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.